ATP, a partial agonist for the P2Z receptor of human lymphocytes
about
Regeneration and tolerance factor prevents bystander T-cell death associated with human immunodeficiency virus infectionThe role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolismPoint mutations confer loss of ATP-induced human P2X(7) receptor functionExpression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids.Purinergic receptors are required for HIV-1 infection of primary human macrophages.P2 purinergic receptor modulation of cytokine production.R270C polymorphism leads to loss of function of the canine P2X7 receptor.Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes.Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cellsRegulation of P2X(7) nucleotide receptor function in human monocytes by extracellular ions and receptor density.4-Aminopyridine activates calcium influx through modulation of the pore-forming purinergic receptor in human peripheral blood mononuclear cells.The P2X(7) receptor from Xenopus laevis: formation of a large pore in Xenopus oocytes.Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
P2860
Q24562769-2402BDBA-D481-4989-BFE5-ABE2C5B4DAF2Q24629291-F3B1CADA-37BE-4208-97AB-B49BCCB69211Q28202244-31FF95BE-D427-4147-A143-9F51F51322BFQ33257485-22B99AB3-334C-4F7B-B590-6562D9350EB3Q36094279-A81A9053-D5DF-49F8-94D2-809C0925F0A6Q36429974-6B663FB5-C912-4069-B872-8691038433A4Q37135491-4FA43DC4-B24F-4BC4-999A-4217CE97744BQ38995440-F4ABA193-5FBB-4EF5-83C1-67DB44903713Q39099142-B1DF0AA6-8BB5-4831-AB0F-2439CFC3CCDFQ39321549-78A879E0-34E2-4A58-AB46-5D2D693181DCQ40468184-6C10F2A9-F21E-4E3A-A9C7-F4B450C66B30Q40859898-82D908C3-377D-4AF4-922B-D083C1FA94B2Q43540365-B19BC299-5F36-433C-8795-C2FF21CE0D10Q44820632-1B518EA3-B14A-4361-A863-5E4A76255B2AQ48865628-78185F4B-B13D-447E-849B-3DB53ADD4E8EQ53702209-92A36BC0-0C7C-4696-A6F4-6493F54838A0
P2860
ATP, a partial agonist for the P2Z receptor of human lymphocytes
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@ast
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@en
type
label
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@ast
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@en
prefLabel
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@ast
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@en
P2860
P356
P1476
ATP, a partial agonist for the P2Z receptor of human lymphocytes
@en
P2093
J E Cornish
P2860
P304
P356
10.1038/SJ.BJP.0701447
P407
P577
1997-11-01T00:00:00Z